Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21392658 | 0.99 | KDM4E (0.33) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL21392496 | 0.95 | ALK (0.33) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL21392657 | 0.95 | KDM4E (0.35) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL26999828 | 0.94 | PLA2G2A (0.33) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL21392618 | 0.94 | MEN1 (0.33) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL26999829 | 0.93 | PLA2G2A (0.32) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL21392601 | 0.93 | MEN1 (0.32) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL25603739 | 0.92 | KDM4E (0.33) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL16996032 | 0.92 | KDM4E (0.32) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL21707841 | 0.91 | KDM4E (0.33) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11877509-B2 | Organic light-emitting element | LG CHEM, LTD. | 2024-01-16 | — | — | US | disclosed |
| US-11877509-B2 | Organic light-emitting element | LG CHEM, LTD. | 2024-01-16 | — | — | US | disclosed |
| US-20190296238-A1 | Organic Light-emitting Element | LG CHEM, LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296238-A1 | Organic Light-emitting Element | CRY1, CRY2, NR2E3 | KDM4E 1903/4885MEN1 1414/4885MAPT 665/4885 |
| US-11877509-B2 | Organic light-emitting element | CRY1, CRY2, NR2E3 | KDM4E 1903/4885MEN1 1414/4885MAPT 665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.